4//SEC Filing
Williams Rosemary Y. 4
Accession 0001628280-20-000160
CIK 0001358403other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 5:15 PM ET
Size
13.9 KB
Accession
0001628280-20-000160
Insider Transaction Report
Form 4
Williams Rosemary Y.
Principal Accounting Officer
Transactions
- Exercise/Conversion
Common Stock
2020-01-02+1,282→ 5,753 total - Tax Payment
Common Stock
2020-01-02$1.51/sh−483$729→ 5,270 total - Tax Payment
Common Stock
2020-01-03$1.40/sh−295$413→ 5,756 total - Exercise/Conversion
Restricted Stock Units
2020-01-02−1,282→ 2,562 total→ Common Stock (1,282 underlying) - Exercise/Conversion
Common Stock
2020-01-03+781→ 6,051 total - Exercise/Conversion
Restricted Stock Units
2020-01-03−781→ 781 total→ Common Stock (781 underlying)
Footnotes (5)
- [F1]Each restricted stock unit represents a contingent right to receive one share of BLCM common stock.
- [F2]Represents the number of shares withheld by and surrendered to the Issuer on January 2, 2020, to satisfy tax withholding obligations that arose in connection with the vesting of the RSUs granted to the reporting person on January 2, 2018 for 5,125 shares.
- [F3]Represents the number of shares withheld by and surrendered to the Issuer on January 3, 2020, to satisfy tax withholding obligations that arose in connection with the vesting of the RSUs granted to the reporting person on January 3, 2017 for 3,125 shares.
- [F4]On January 2, 2018, the reporting person was granted 5,125 RSUs, of which 1,282 vested on January 2, 2020. The RSUs vest in four annual installments beginning January 2, 2019.
- [F5]On January 3, 2017, the reporting person was granted 3,125 RSUs, of which 781 vested on January 3, 2020. The RSUs vest in four annual installments beginning January 3, 2018.
Documents
Issuer
BELLICUM PHARMACEUTICALS, INC
CIK 0001358403
Entity typeother
Related Parties
1- filerCIK 0001747727
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 5:15 PM ET
- Size
- 13.9 KB